Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

In its first major refresh since its establishment in 2018, the BioEscalator is delighted to welcome five leading University of Oxford academics and innovators to its Management Board. The Management Board provides a source of expertise for BioEscalator tenants and works to enhance research at the University by building strong links with small life sciences companies.

Five board members

Peter Callow is a seasoned finance executive with extensive international experience in financial management, strategic planning, and leadership.

Professor Catherine Green OBE is Head of the Clinical Biomanufacturing Facility at Nuffield Department of Medicine and Associate Professor in Chromosome Dynamics at the Centre for Human Genetics. She played a key role in developing the Oxford/AstraZeneca Covid-19 vaccine.

Professor Bethan Psaila is an Associate Professor of Haematology and Cancer Research at MRC Weatherall Institute of Molecular Medicine; she is also Co-founder of a blood malignancies company and BioEscalator tenant Alethiomics.

Professor Molly Stevens DBE is John Black Professor of Bionanoscience at the Institute of Biomedical Engineering and the Department of Physiology, Anatomy & Genetics and research director for biomedical materials at Imperial College London.

Professor Krina Zondervan is Head of the Nuffield Department of Women's & Reproductive Health, Professor of Reproductive and Genomic Epidemiology, and Co-Director of the Endometriosis Care Centre.

 

Read the full story on the BioEScalator website.